Central Texas Neurology

Round Rock, Texas 78681

1 studies enrolling now · 12 studies all time

What they study most

Autoimmune Diseases of the Nervous System, Brain Atrophy, Clinically Isolated Syndrome, Cognition Disorders, Deep Brain Stimulation, Disease Progression, Healthy Participants, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Parkinson Disease, Parkinson's Disease (PD), Relapsing-Remitting Multiple Sclerosis

Studies at this site

• A Study of Buntanetap in Participants With PD — Recruiting now
• A Study of TAK-071 in People With Parkinson Disease — Completed
• Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis — Completed
• Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis — Stopped early
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed
• Autologous T Cell Vaccine (TCV) for Multiple Sclerosis — Completed
• Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy — Completed
• Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis — Completed
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis — Completed
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis — Completed